Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,870.00
-400.00 (-4.84%)
At close: Mar 31, 2026

KOSDAQ:036480 Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
25,98923,80425,56225,50023,997
Other Revenue
-0-0-0-0-0
25,98923,80425,56225,50023,997
Revenue Growth (YoY)
9.18%-6.88%0.24%6.26%-3.24%
Cost of Revenue
19,66919,87220,85720,85518,404
Gross Profit
6,3203,9324,7054,6455,593
Selling, General & Admin
4,8944,7724,7894,3544,694
Amortization of Goodwill & Intangibles
121.37139.81190.8200.28131.44
Other Operating Expenses
89.3388.6287.2782.98122.37
Operating Expenses
5,6065,4845,3944,9735,256
Operating Income
714.27-1,552-689.01-327.52337.11
Interest Expense
-605.12-846.16-892.67-512.58-277.53
Interest & Investment Income
216.41296.55374.42213.88119.03
Earnings From Equity Investments
-38.7-27.736.39-14.6-4.97
Currency Exchange Gain (Loss)
-0.9548.4858.67478.31566.84
Other Non Operating Income (Expenses)
30-6.5630.83205.0195.4
EBT Excluding Unusual Items
315.96-1,587-1,08142.49835.87
Gain (Loss) on Sale of Investments
-0.07-0.19-0.29-0.91-
Gain (Loss) on Sale of Assets
19.0416.26-0.072,2197
Pretax Income
334.93-1,571-1,0822,261842.87
Income Tax Expense
-263.26198.32-402.05557.38-23.05
Net Income
598.19-1,769-679.681,703865.92
Net Income to Common
598.19-1,769-679.681,703865.92
Net Income Growth
---96.69%-42.98%
Shares Outstanding (Basic)
-4444
Shares Outstanding (Diluted)
-4444
EPS (Basic)
--465.62-178.86448.21227.87
EPS (Diluted)
--465.62-178.86448.21227.87
EPS Growth
---96.69%-42.98%
Free Cash Flow
1,0541,308-2,490-1,160-764.71
Free Cash Flow Per Share
-344.14-655.25-305.18-201.24
Gross Margin
24.32%16.52%18.40%18.22%23.31%
Operating Margin
2.75%-6.52%-2.70%-1.28%1.41%
Profit Margin
2.30%-7.43%-2.66%6.68%3.61%
Free Cash Flow Margin
4.06%5.49%-9.74%-4.55%-3.19%
EBITDA
3,255163.172,1732,3782,875
EBITDA Margin
12.52%0.69%8.50%9.33%11.98%
D&A For EBITDA
2,5401,7152,8622,7062,538
EBIT
714.27-1,552-689.01-327.52337.11
EBIT Margin
2.75%-6.52%-2.70%-1.28%1.41%
Effective Tax Rate
---24.66%-
Advertising Expenses
153.45149.24176.851.04122.44
Source: S&P Global Market Intelligence. Standard template. Financial Sources.